urapidil has been researched along with Urinary Bladder, Neurogenic in 3 studies
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamanishi, T | 3 |
| Yasuda, K | 3 |
| Tojo, M | 1 |
| Hattori, T | 1 |
| Sakakibara, R | 1 |
| Shimazaki, J | 1 |
| Kawabe, K | 2 |
| Ohshima, H | 1 |
| Morita, T | 2 |
| Homma, Y | 1 |
2 trials available for urapidil and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
The effect of urapidil on neurogenic bladder: a placebo controlled double-blind study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; M | 1996 |
A multicenter placebo-controlled, double-blind trial of urapidil, an alpha-blocker, on neurogenic bladder dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up | 1999 |
1 other study available for urapidil and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pipe | 1994 |